PMID: 42387310

Efficacy and Safety of Intensifying Once-Weekly Insulin Icodec Treatment With Once-Weekly Semaglutide in Adults With Type 2 Diabetes: A Single-Arm, Open-Label, Treat-to-Target, Phase 3b Trial (ONWARDS 8).

Strojek Krzysztof, Liebl Andreas, Mumbaikar Neha Narendra, Søgaard Stinne Byrholdt, Kehlet Watt Sara, Philis-Tsimikas Athena

Diabetes, obesity & metabolism · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.